Vincent Manganiello. Show Affiliations »
Abstract
Mesh: See more » 3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors3',5'-Cyclic-AMP Phosphodiesterases/metabolism3',5'-Cyclic-GMP Phosphodiesterases/antagonists & inhibitors3',5'-Cyclic-GMP Phosphodiesterases/metabolismAnimalsCardiovascular Diseases/drug therapyCardiovascular Diseases/metabolismEndocrine System Diseases/drug therapyEndocrine System Diseases/metabolismHumansIsoenzymes/antagonists & inhibitorsIsoenzymes/metabolismMetabolic Diseases/drug therapyMetabolic Diseases/metabolismMolecular Targeted TherapyPhosphodiesterase Inhibitors/pharmacologyPhosphodiesterase Inhibitors/therapeutic useSecond Messenger Systems/drug effects
Substances: See more » IsoenzymesPhosphodiesterase Inhibitors3',5'-Cyclic-AMP Phosphodiesterases3',5'-Cyclic-GMP Phosphodiesterases
Year: 2011 PMID: 22079477 DOI: 10.1016/j.coph.2011.10.016
Source DB: PubMed Journal: Curr Opin Pharmacol ISSN: 1471-4892 Impact factor: 5.547